Laying the foundation for next generation inflammation therapies.
Approach
We have a focused strategy to solve the major challenges that chronic inflammation presents.
Our aim is to identify and advance potent, highly selective molecules with distinctive mechanisms of action that we believe have the highest potential for clinical advancement. Top investigative candidates are guided forward by teams with proven expertise in biotech innovation.
“Available medicines have made progress treating inflammation, but we know there’s a need for safer, more effective therapies. That’s where Evommune will make a difference.”
Luis Peña, President & CEO
Our Pillars
The core of our approach is leveraging a powerful structure-based drug discovery engine along with our deep scientific, clinical, and commercial expertise to drive target selection and the design of novel molecules that have the potential to safely and efficaciously address the root cause of inflammation.